158 related articles for article (PubMed ID: 300547)
1. Effect of long-term vitamin D2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia.
Mosekilde L; Melsen F; Christensen MS; Lund B; Sorenson OH
Acta Med Scand; 1977; 201(4):303-7. PubMed ID: 300547
[TBL] [Abstract][Full Text] [Related]
2. Interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and morphometric bone changes in anticonvulsant osteomalacia. Therapeutic effect of vitamin D2.
Melsen F; Mosekilde L; Christensen MS; Lund B; Sorensen OH
Calcif Tissue Res; 1977 May; 22 Suppl():473-8. PubMed ID: 303141
[No Abstract] [Full Text] [Related]
3. Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy.
Hoikka V; Savolainen K; Karjalainen P; Alhava EM; Sivenius J
Ann Clin Res; 1982 Apr; 14(2):72-5. PubMed ID: 6983324
[TBL] [Abstract][Full Text] [Related]
4. The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia.
Mosekilde L; Christensen MS; Lund B; Sorensen OH; Melsen F
Acta Endocrinol (Copenh); 1977 Mar; 84(3):559-65. PubMed ID: 576530
[TBL] [Abstract][Full Text] [Related]
5. Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia.
Christiansen C; Rodbro P; Munck O
Br Med J; 1975 May; 2(5967):363-5. PubMed ID: 165857
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D metabolism and osteomalacia in cystic fibrosis.
Friedman HZ; Langman CB; Favus MJ
Gastroenterology; 1985 Mar; 88(3):808-13. PubMed ID: 3871414
[TBL] [Abstract][Full Text] [Related]
7. Osteomalacia with long-term anticonvulsant therapy in epilepsy.
Dent CE; Richens A; Rowe DJ; Stamp TC
Br Med J; 1970 Oct; 4(5727):69-72. PubMed ID: 5312062
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant drug-induced osteomalacia: alterations in mineral metabolism and response to vitamin D3 administration.
Hahn TJ; Halstead LR
Calcif Tissue Int; 1979 Mar; 27(1):13-8. PubMed ID: 223750
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia.
Lyles KW; Harrelson JM; Drezner MK
J Clin Endocrinol Metab; 1982 Feb; 54(2):307-15. PubMed ID: 6976353
[No Abstract] [Full Text] [Related]
10. The frequency of bone abnormality in patients on anticonvulsant therapy.
Jowsey J; Arnaud SB; Hodgson SF; Johnson KA; Beabout JW; Wahner HW
Electroencephalogr Clin Neurophysiol; 1978 Sep; 45(3):341-7. PubMed ID: 79473
[TBL] [Abstract][Full Text] [Related]
11. Treatment of anticonvulsant osteomalacia with vitamin D.
Christiansen C; Rodbro P
Calcif Tissue Res; 1976 Aug; 21 Suppl():252-9. PubMed ID: 782665
[No Abstract] [Full Text] [Related]
12. Initial and maintenance dose of vitamin D2 in the treatment of anticonvulsant osteomalacia.
Christiansen C; Rodbro P
Acta Neurol Scand; 1974; 50(5):631-41. PubMed ID: 4547902
[No Abstract] [Full Text] [Related]
13. Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy. Short-term effect of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol.
Mosekilde L; Hansen HH; Christensen MS; Lund B; Sørensen OH; Melsen F; Norman AW
Acta Med Scand; 1979; 205(5):405-9. PubMed ID: 443080
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs.
Stamp TC; Round JM; Rowe DJ; Haddad JG
Br Med J; 1972 Oct; 4(5831):9-12. PubMed ID: 4342760
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology behind anticonvulsant osteomalacia.
Christiansen C; Rødbro P; Tjellesen L
Acta Neurol Scand Suppl; 1983; 94():21-8. PubMed ID: 6576595
[TBL] [Abstract][Full Text] [Related]
16. Osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy.
Hoikka V; Savolainen K; Alhava EM; Sivenius J; Karjalainen P; Repo A
Acta Neurol Scand; 1981 Aug; 64(2):122-31. PubMed ID: 7324878
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of anticonvulsant osteomalacia in adults (author's transl)].
Krause KH; Prager P; Schmidt-Gayk H; Ritz E
Dtsch Med Wochenschr; 1977 Dec; 102(51):1872-7. PubMed ID: 598289
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin D2 and D3 on bone-mineral content in carbamazepine-treated epileptic patients.
Tjellesen L; Gotfredsen A; Christiansen C
Acta Neurol Scand; 1983 Dec; 68(6):424-8. PubMed ID: 6320577
[TBL] [Abstract][Full Text] [Related]
19. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment.
Weinstein RS; Bryce GF; Sappington LJ; King DW; Gallagher BB
J Clin Endocrinol Metab; 1984 Jun; 58(6):1003-9. PubMed ID: 6725504
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant osteomalacia in epileptic outpatients.
Hoikka V; Savolainen K; Alhava EM; Sivenius J; Karjalainen P; Parvianinen M
Ann Clin Res; 1982 Jun; 14(3):129-32. PubMed ID: 7137882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
